Shorts

1:26
Ensuring Treatment Access Remains Central Challenge in Lung Cancer Care: Deborah Doroshow, MD, PhD
6 months ago
by
Brooke McCormick(+2 more)

0:44
Why Local Cancer Care Is in Crisis: Kathy Oubre, MS
6 months ago
by
Maggie L. Shaw(+1 more)

2:17
History of Medicine Offers Lessons for Modern Cancer Care: Deborah Doroshow, MD, PhD
6 months ago
by
Brooke McCormick(+2 more)

2:28
AJMC Research Roundup: April 2026
6 months ago
by
Christina Mattina

2:13
Study Finds Minimal Shifts in Primary Care Selection Following Benefit Design Changes: Tim McDonald, PhD, MPP
6 months ago
by
Brooke McCormick(+1 more)

1:33
Consumer Inertia, Information Gaps Contribute to Inefficiency in Health Care Markets: Bryan E. Dowd, PhD
6 months ago
by
Brooke McCormick(+1 more)

0:40
Efgartigimod Will Likely Be Used as Second-Line Treatment for oMG: Carolina Barnett-Tapia, MD, PhD
6 months ago
by
Julia Bonavitacola(+1 more)

1:11
BCBSNC Foundation Reflects on 25 Years, Looks Ahead With Renewed Purpose: Katie Eyes, MSW
6 months ago
by
Brooke McCormick(+1 more)

0:33
School Nurses Do Way More Than You Think: Shara Bialo, MD
6 months ago
by
Pearl Steinzor(+1 more)

0:53
Why Nurse Navigators are Vital to Oncology Care: Christopher A. D'Avella, MD
6 months ago
by
Giuliana Grossi(+1 more)

2:00
BCBSNC Foundation’s Strategy Focuses on Communities, Long-Term Investment, and Root Causes of Health Gaps: Colleen Briggs, MBA
6 months ago
by
Brooke McCormick(+1 more)

0:37
An Inflection Point in Specialty Pharmacy: Fran Gregory, PharmD
6 months ago
by
Laura Joszt, MA(+1 more)

0:52
The State of Specialty Pharmacy Is Changing Fast
6 months ago
by
Laura Joszt, MA(+1 more)

0:39
A Medical Misdiagnosis That Led to a Child Protection Case: Joseph Lam, MD
6 months ago
by
Pearl Steinzor(+1 more)

0:52
Why Infection Prevention Lags Behind Cancer Research: Muhammad Bilal Abid, MD
6 months ago
by
Sabrina McCrear(+1 more)

0:36
Why Pediatric Practices Struggle With Accepting Medicaid: Chris Johnson, MBA
6 months ago
by
Giuliana Grossi(+1 more)

1:31
Is the New COVID-19 “Cicada” Variant Dangerous?: Muhammad Bilal Abid, MD
6 months ago
by
Sabrina McCrear(+1 more)

1:18
Barriers to Community Oncology Care Referral: Alexa Simon Meara, MD, MS
6 months ago
by
Maggie L. Shaw(+1 more)

0:44
Why PrEP Options Are Changing Everything: Kelsea Aragon, PharmD
6 months ago
by
Sabrina McCrear(+1 more)

0:53
Community Oncology Advocacy Difficult, but Not Impossible: Kathy Oubre, MS
6 months ago
by
Maggie L. Shaw(+1 more)

0:55
Why Your Prescription Costs Are Outpacing Your Wages: Ulrich Neumann
6 months ago
by
Sabrina McCrear(+1 more)

0:56
Why Step Therapy Fails in HIV Prevention: Kelsea Aragon, PharmD
6 months ago
by
Sabrina McCrear(+1 more)

0:43
Life-Saving Gene Therapies Cost Up to $4 Million: Fran Gregory, PharmD, MBA
7 months ago
by
Pearl Steinzor(+1 more)

0:34
Where Oncology Connects and AI Takes Center Stage: Stephen Schleicher, MD, MBA
7 months ago
by
Maggie L. Shaw(+1 more)

0:52
Treprostinil Shows Promise as Potential First Inhaled IPF Therapy: Steven D. Nathan, MD
7 months ago
by
Sabrina McCrear(+1 more)

0:37
A New Milestone in IPF Treatment, Breaking Down the TITOn-1 Results: Steven D. Nathan, MD
7 months ago
by
Sabrina McCrear(+1 more)

0:45
Goals of the Bispecifics Network: Learning How to Operationalize Bispecifics
7 months ago
by
Olalekan Ajayi, PharmD, MBA, FACC(+1 more)

1:03
Sub-Q Amivantamab Reduces Clinic Visits, Infusion Reactions in EGFR-Mutated NSCLC: Estelamari Rodriguez, MD, MPH
7 months ago
by
Brooke McCormick(+1 more)

2:02
Managed Care Experts Return to Music City for AMCP 2026: Susan Cantrell
7 months ago
by
Brooke McCormick(+1 more)

0:35
The "Red Crayon" Bias in Dermatology: Joseph Lam, MD
7 months ago
by
Pearl Steinzor(+1 more)
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
Pharmacy, Claims Data Show High Resmetirom Persistence in MASH
4
FDA Approves First Dual-Targeted Therapy for Advanced HNSCC
5
